InTechnology · 2024-12-02 · 35 min
In this InTechnology episode, Camille Morhardt discusses the application of artificial intelligence (AI) in the biopharmaceutical and life sciences sectors with Prashant Shah, Intel's CTO for federated artificial intelligence products, and Abhishek Pandey, a global lead and principal research scientist at AbbVie. The conversation centers on the potential of AI, particularly federated learning, to revolutionize drug discovery and development. They explore the challenges of data privacy and IP protection in this context, emphasizing the importance of collaboration and the role of initiatives like OpenFL and MLCommons in setting standards for AI in the industry. The views and opinions expressed are those of the guests and author and do not necessarily reflect the official policy or position of Intel Corporation.
221. From Smart Devices to Supply Chain: Lenovo's Blueprint for Trust in Tech
220. Increasing Visibility of the Device Supply Chain to Improve Cybersecurity: Solutions from Lenovo and Intel
219. Personalized Marketing: How Movable Ink Delivers with AI and Automation
218. What Keeps IT Leaders Up at Night? The Complexities of Cloud Security and Data Sovereignty
216. Securing Tomorrow: How Fortanix is Shaping the Future of Data Protection